Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ:072020)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,760.00
0.00 (0.00%)
At close: Feb 19, 2026
Market Cap92.70B -1.8%
Revenue (ttm)39.19B -4.2%
Net Income3.65B -55.6%
EPS375.11 -55.1%
Shares Out9.46M
PE Ratio26.13
Forward PEn/a
Dividend200.00 (2.05%)
Ex-Dividend DateDec 29, 2025
Volume48,181
Average Volume52,612
Open9,800.00
Previous Closen/a
Day's Range9,670.00 - 9,840.00
52-Week Range9,200.00 - 10,500.00
Beta0.50
RSI61.63
Earnings DateMar 20, 2026

About KOSDAQ:072020

Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1968
Employees 167
Stock Exchange KOSDAQ
Ticker Symbol 072020
Full Company Profile

Financial Performance

In 2022, KOSDAQ:072020's revenue was 39.30 billion, a decrease of -3.95% compared to the previous year's 40.91 billion. Earnings were 4.04 billion, a decrease of -46.80%.

Financial Statements